Quorum Health (NYSE: QHC) is one of 15 public companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it contrast to its competitors? We will compare Quorum Health to related businesses based on the strength of its institutional ownership, dividends, valuation, earnings, profitability, analyst recommendations and risk.

Valuation and Earnings

This table compares Quorum Health and its competitors revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Quorum Health $2.42 billion -$347.68 million -0.69
Quorum Health Competitors $1.06 billion -$22.56 million 748.59

Quorum Health has higher revenue, but lower earnings than its competitors. Quorum Health is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

81.7% of Quorum Health shares are held by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 4.7% of Quorum Health shares are held by insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Quorum Health and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quorum Health 1 3 0 0 1.75
Quorum Health Competitors 57 326 509 9 2.52

Quorum Health presently has a consensus price target of $3.88, suggesting a potential downside of 10.30%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 21.59%. Given Quorum Health’s competitors stronger consensus rating and higher possible upside, analysts plainly believe Quorum Health has less favorable growth aspects than its competitors.

Risk and Volatility

Quorum Health has a beta of 7.53, suggesting that its share price is 653% more volatile than the S&P 500. Comparatively, Quorum Health’s competitors have a beta of 1.47, suggesting that their average share price is 47% more volatile than the S&P 500.

Profitability

This table compares Quorum Health and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Quorum Health -8.28% -38.34% -3.34%
Quorum Health Competitors 3.52% 3.52% 4.31%

Summary

Quorum Health competitors beat Quorum Health on 9 of the 12 factors compared.

Quorum Health Company Profile

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR). It operates QHR, which is a hospital management advisory and consulting services that provides services to non-affiliated general acute care hospitals. Its hospitals and its affiliated businesses offer services, such as general acute care, emergency room, general and specialty surgery and rehabilitation services.

Receive News & Stock Ratings for Quorum Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health Corp and related stocks with our FREE daily email newsletter.